Entospletinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Entospletinib, covering 2018-12-26 to 2024-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML [Phase 3]